Ireland - English - HPRA (Health Products Regulatory Authority)

ucb pharma limited - a/sydney /5/97 (h3n2)-like strain a/beijing /262/95 (h1n1)-like strain b/beijing /184/93-like strain - 5 millilitre

Ireland - English - HPRA (Health Products Regulatory Authority)

ucb pharma limited - a/sydney /5/97 (h3n2)-like strain a/beijing /262/95 (h1n1)-like strain b/beijing /184/93-like strain - 0.5 millilitre

Ireland - English - HPRA (Health Products Regulatory Authority)

ucb pharma limited - a/sydney /5/97 (h3n2)-like strain a/beijing /262/95 (h1n1)-like strain b/beijing /184/93-like strain - 0.5 millilitre

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott healthcare products ltd - a/sydney /5/97 (h3n2)-like strain a/beijing /262/95 (h1n1)-like strain b/beijing /184/93-like strain influenza virus inactivated strain a/equi-2/miami/63 - suspension for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - influenza virus a/darwin/9/2021 (h3n2)-like strain 15ug (a/darwin/9/2021 san-010 ); influenza virus a/sydney/5/2021 (h1n1) pdm09-like strain 15ug (a/sydney/5/2021, san-013); influenza virus b/austria/1359417/2021-like strain 15ug (b/michigan/01/2021 wild type ); influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013 wild type ) - suspension for injection - 60 mcg - active: influenza virus a/darwin/9/2021 (h3n2)-like strain 15ug (a/darwin/9/2021 san-010 ) influenza virus a/sydney/5/2021 (h1n1) pdm09-like strain 15ug (a/sydney/5/2021, san-013) influenza virus b/austria/1359417/2021-like strain 15ug (b/michigan/01/2021 wild type ) influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013 wild type ) excipient: octoxinol 9 phosphate buffered saline - fluquadri is indicated for active immunisation of influenza disease caused by influenza a subtype viruses and type b viruses contained in the vaccine. fluquadri is indicated for use in adults and children 6 months and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - influenza virus a/darwin/9/2021 (h3n2)-like strain 15ug (a/darwin/9/2021, san 010); influenza virus a/sydney/5/2021 (h1n1) pdm09-like strain 15ug (a/sydney/5/2021, san 013); influenza virus b/austria/1359417/2021-like strain 15ug (b/austria/1359417/2021, bvr-26); influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type) - suspension for injection - 0.5 ml - active: influenza virus a/darwin/9/2021 (h3n2)-like strain 15ug (a/darwin/9/2021, san 010) influenza virus a/sydney/5/2021 (h1n1) pdm09-like strain 15ug (a/sydney/5/2021, san 013) influenza virus b/austria/1359417/2021-like strain 15ug (b/austria/1359417/2021, bvr-26) influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type) excipient: calcium chloride dihydrate dibasic sodium phosphate as dihydrate 0.67 mg magnesium chloride hexahydrate monobasic potassium phosphate potassium chloride sodium chloride water for injection - for the prevention of influenza caused by influenza virus, types a and b. for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines. influvac tetra is indicated in adults and children from 6 months of age and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - influenza virus a/california/7/2009 (h1n1) - like strain 9ug (a/california/7/2009 nymc x-179a); influenza virus a/texas/50/2012 (h3n2) like strain 9ug (a/texas/50/2012 nymc x-223a); influenza virus b/massachusetts/2/2012 like strain 9ug (wild type) - suspension for injection - 9 mcg - active: influenza virus a/california/7/2009 (h1n1) - like strain 9ug (a/california/7/2009 nymc x-179a) influenza virus a/texas/50/2012 (h3n2) like strain 9ug (a/texas/50/2012 nymc x-223a) influenza virus b/massachusetts/2/2012 like strain 9ug (wild type) excipient: dibasic sodium phosphate dihydrate hydrochloric acid monobasic potassium phosphate potassium chloride sodium chloride sodium hydroxide water for injection - intanza 9mcg is indicated for prophylaxis of influenza in adults from 18 to 59 years of age. the use of intanza 9mcg in new zealand should be based on the ministry of health recommendations for influenza vaccination as published in the current new zealand immunisation handbook.

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - influenza virus a/darwin/9/2021 (h3n2)-like strain 15ug (a/darwin/6/2021 (ivr-227) ); influenza virus a/sydney/5/2021 (h1n1) pdm09-like strain 15ug (a/sydney/175/2022 ivr-235); influenza virus b/austria/1359417/2021-like strain 15ug (b/austria/1359417/2021 (bvr-26) ); influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013 bvr-1b) - suspension for injection - 60 mcg/0.5ml - active: influenza virus a/darwin/9/2021 (h3n2)-like strain 15ug (a/darwin/6/2021 (ivr-227) ) influenza virus a/sydney/5/2021 (h1n1) pdm09-like strain 15ug (a/sydney/175/2022 ivr-235) influenza virus b/austria/1359417/2021-like strain 15ug (b/austria/1359417/2021 (bvr-26) ) influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013 bvr-1b) excipient: calcium chloride dihydrate citric acid monohydrate dibasic sodium phosphate dihydrate magnesium chloride hexahydrate monobasic potassium phosphate polysorbate 80 potassium chloride sodium chloride sodium citrate dihydrate sorbitan trioleate squalene water for injection - active immunisation against influenza in persons 65 years of age and older.

Canada - English - Health Canada

sanofi pasteur limited - a/panama/2007/99 (h3n2) -like strain; a/new caledonia/20/99(h1n1)-like strain; b/hong kong/1434/2002-like strain - suspension - 15mcg; 15mcg; 15mcg - a/panama/2007/99 (h3n2) -like strain 15mcg; a/new caledonia/20/99(h1n1)-like strain 15mcg; b/hong kong/1434/2002-like strain 15mcg - vaccines

Ireland - English - HPRA (Health Products Regulatory Authority)

chiron vaccines limited - a/singapore686 - like strain (h1n1) a/wuhan /359/95 (h3n2)-like strain b/beijing /184/93-like strain - suspension for injection - %v/v